Drug Price Trends for NP THYROID

Average Pharmacy Cost for NP THYROID

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
NP THYROID 60 MG TABLET	42192-0330-01	0.62585	EACH	2024-12-18
NP THYROID 120 MG TABLET	42192-0328-01	1.15000	EACH	2024-12-18
NP THYROID 90 MG TABLET	42192-0331-01	0.94307	EACH	2024-12-18
NP THYROID 15 MG TABLET	42192-0327-01	0.49836	EACH	2024-12-18
NP THYROID 30 MG TABLET	42192-0329-01	0.56977	EACH	2024-12-18
NP THYROID 60 MG TABLET	42192-0330-01	0.60100	EACH	2024-11-20
NP THYROID 120 MG TABLET	42192-0328-01	1.08290	EACH	2024-11-20

NP THYROID Market Analysis and Financial Projection

Market Analysis and Price Projections for NP Thyroid

Market Overview

The market for thyroid gland disorder treatments, including NP Thyroid, is experiencing significant growth driven by several key factors. The global thyroid gland disorder treatment market was valued at USD 2.22 billion in 2023 and is projected to grow at a CAGR of 3.6% from 2024 to 2030[1].

Prevalence of Thyroid Disorders

The increasing prevalence of hypothyroidism and hyperthyroidism, largely due to the aging population, autoimmune diseases, and iodine deficiency, is a major driver of the market. Hypothyroidism, in particular, is a common condition where the thyroid gland does not produce enough thyroid hormone, with Hashimoto’s disease being the most common cause[2].

NP Thyroid: A Key Treatment Option

NP Thyroid is a prescription drug used to treat hypothyroidism. It contains tetraiodothyronine sodium (T4; levothyroxine) and triiodothyronine sodium (T3; liothyronine), making it a comprehensive treatment for underactive thyroid conditions[2].

Market Segmentation and Growth

The oral segment of thyroid medications, which includes NP Thyroid, accounted for the largest market revenue share of 57.1% in 2023. This dominance is due to the high bioavailability, rapid drug delivery, and high efficacy of oral medications. The oral segment is expected to continue growing, driven by new product developments and the convenience of administration[1].

Regional Market Analysis

• North America: This region dominated the global market with a revenue share of over 35.44% in 2023. The U.S. market, in particular, accounted for a 29.4% share of the global market, driven by improved healthcare facilities, new product launches, and FDA approvals[1].
• Asia Pacific: This region is anticipated to witness significant growth due to the rising geriatric population and the focus on developing low-cost, high-efficiency products[1].
• MEA: Despite holding a low market share, the Middle East and Africa region is expected to grow due to increasing public awareness and demographic shifts such as urbanization and lifestyle changes[1].

Distribution Channels

Wholesale distribution currently holds the largest market revenue share of 46.7%, thanks to high discounts on bulk purchases and quick services. However, the online pharmacy segment is expected to grow significantly at a CAGR of 3.9% during the forecast period, driven by the convenience, accessibility, and price comparison capabilities of eCommerce channels[1].

Price Projections and Affordability

The cost of NP Thyroid varies based on the dosage and pharmacy. Here are some average prices:

• 15 mg oral tablet: Around $85 for a supply of 100 tablets[5].
• 30 mg oral tablet: From $38.93 for 100 tablets[5].
• 60 mg oral tablet: From $37.47 for 100 tablets[5].

Using discount programs and coupons can significantly reduce the cost. For example, a SingleCare coupon can lower the price of NP Thyroid to as low as $83.99 for 90 tablets[2].

Challenges and Recalls

Acella Pharmaceuticals, the manufacturer of NP Thyroid, has faced issues with product potency. In 2021, the company recalled several lots of NP Thyroid due to batches containing less than 90% of the labeled amount of liothyronine and levothyroxine, leading to reports of serious side effects[4].

Future Trends and Strategies

The market is expected to see steady growth driven by patient awareness and education, healthcare expenditure, and global economic conditions. Trends include the development of thyroid surgery and radioactive iodine alternatives, patient-centric care, and the integration of telemedicine and remote monitoring[3].

Key Takeaways

• The global thyroid gland disorder treatment market is growing at a CAGR of 3.6% from 2024 to 2030.
• NP Thyroid is a significant player in the oral segment, which dominates the market.
• Regional growth is driven by factors such as improved healthcare facilities, new product launches, and increasing public awareness.
• Distribution channels are shifting towards online pharmacies due to convenience and cost-effectiveness.
• Price variability exists, but discount programs can make the medication more affordable.
• Manufacturers face challenges such as product potency issues, which can impact market trust and growth.

FAQs

Q: What is NP Thyroid used for? NP Thyroid is used to treat hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormone. It is particularly effective for conditions like Hashimoto’s disease[2].

Q: What are the ingredients in NP Thyroid? NP Thyroid contains tetraiodothyronine sodium (T4; levothyroxine) and triiodothyronine sodium (T3; liothyronine)[2].

Q: How much does NP Thyroid cost? The cost of NP Thyroid varies by dosage and pharmacy, but on average, it can range from $38.93 for 100 tablets of the 30 mg dose to $85 for 100 tablets of the 15 mg dose. Discount programs can reduce these costs[5].

Q: Why was NP Thyroid recalled in 2021? NP Thyroid was recalled in 2021 due to batches containing less than 90% of the labeled amount of liothyronine and levothyroxine, leading to reports of serious side effects[4].

Q: What are the future trends in the thyroid gland disorder treatment market? Future trends include the development of thyroid surgery and radioactive iodine alternatives, patient-centric care, and the integration of telemedicine and remote monitoring[3].

Cited Sources

1. Grand View Research - Thyroid Gland Disorder Treatment Market Size Report, 2030
2. SingleCare - Np Thyroid Coupons & Prices
3. The Business Research Company - Anti-Thyroid Drugs Global Market Report 2024
4. FiercePharma - Acella facing 43 'serious' side effect reports, pulls dozens of lots of sub-potent thyroid
5. Drugs.com - NP Thyroid Prices, Coupons, Copay Cards & Patient Assistance